AHR and urothelial carcinoma: This is in line with another study on urothelial carcinoma cells, which found that AhR ligands like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) upregulate expression of matrix metalloproteinases in vitro.